CLINICAL TRIALS PROFILE FOR HYDROCORTISONE SODIUM SUCCINATE
✉ Email this page to a colleague
All Clinical Trials for hydrocortisone sodium succinate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002757 ↗ | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | Completed | Children's Cancer and Leukaemia Group | Phase 3 | 2001-06-01 | RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma. |
| NCT00002757 ↗ | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | Completed | National Cancer Institute (NCI) | Phase 3 | 2001-06-01 | RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma. |
| NCT00002757 ↗ | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | Completed | Societe Francaise Oncologie Pediatrique | Phase 3 | 2001-06-01 | RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma. |
| NCT00002757 ↗ | TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma | Completed | Children's Oncology Group | Phase 3 | 2001-06-01 | RATIONALE: Less intensive therapy may attain in the same results as intensive therapy in children with non-Hodgkin's lymphoma. PURPOSE: Randomized phase III trial to study the effectiveness of less intensive therapy for children who have non-Hodgkin's lymphoma. |
| NCT00002805 ↗ | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | Completed | National Cancer Institute (NCI) | Phase 2 | 1997-08-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with acute myeloid leukemia or myelodysplastic syndrome in first relapse or who did not achieve first remission. |
| NCT00002805 ↗ | Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | Completed | Children's Oncology Group | Phase 2 | 1997-08-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with acute myeloid leukemia or myelodysplastic syndrome in first relapse or who did not achieve first remission. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for hydrocortisone sodium succinate
Condition Name
Clinical Trial Locations for hydrocortisone sodium succinate
Trials by Country
Clinical Trial Progress for hydrocortisone sodium succinate
Clinical Trial Phase
Clinical Trial Sponsors for hydrocortisone sodium succinate
Sponsor Name
